Join to View Full Profile
101 The City Dr S# CityOrange, CA 92868
Phone+1 714-456-6693
Dr. Naqvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Ali Naqvi, MD, is a Cardiologist based in Orange, CA. He is currently an Assistant Clinical Professor at UCI Health, a position he has held since 2021. He was also the Chief Resident at UCI Health starting year 2017. Dr. Naqvi completed his fellowship in Cardiovascular Disease and his Residency in Internal Medicine at the University of California (Irvine). His medical degree was obtained from Tufts University School of Medicine in 2014. Dr. Naqvi has contributed to the field through various publications in reputable journals such as Atherosclerosis and Future Cardiology, receiving several citations.
Education & Training
University of California (Irvine)Fellowship, Cardiovascular Disease, 2018 - 2021- University of California (Irvine)Residency, Internal Medicine, 2014 - 2017
Tufts University School of MedicineClass of 2014
Certifications & Licensure
CA State Medical License 2015 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy.Aya F Ozaki, Michael Sayer, Hirofumi Hamano, Misako Nagasaka, Benjamin J Lee
Cardio-Oncology. 2025-03-05 - 2 citationsSex-based disparities with cost-related medication adherence issues in patients with hypertension, ischemic heart disease, and heart failure.Ivann Agapito, Tu Hoang, Michael Sayer, Ali Naqvi, Pranav M Patel
Journal of the American Medical Informatics Association. 2024-12-01 - 12 citationsUtility of novel serum biomarkers to predict subclinical atherosclerosis: A sub-analysis of the EISNER study.Shuktika Nandkeolyar, Ali Naqvi, Wenjun Fan, Ajay N. Sharma, Jamal S. Rana
Atherosclerosis. 2019-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
